AHFS Drug Information 2016

With extensive updated information on everything from treatment of hypertension to HIV, AHFS Drug Information® 2016 is a necessary addition to your pharmacy’s resources. With content supported by more than 86,000 total references and reviewed by over 500 professionals, AHFS DI® helps you protect your patients and your business. The only print compendium designated by the U.S. Congress, AHFS DI 2016 is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 58 years.
AHFS DI contains the most trustworthy drug information available - all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
Updates for this edition include:

Expanded and revised content throughout, featuring critical new  monograph updates every year
Important updated monographs and references related to revised therapeutic guidelines, including recommendations for the treatment of hypertension, elevated cholesterol, and HIV infections
Newly published information on breakthrough oncology drugs recently approved as part of the FDA’s accelerated approval program
Dedicated coverage to orphan products
Interactions, adverse reactions, cautions, and more
Therapeutic recommendations supported by evidence from primary research
Preparations, chemistry, and stability
Pharmacology and pharmacokinetics
Prescription, OTC, ophthalmic and dermatologic drugs
Extensive off-label uses and dosing options
Vaccines and other immunizing agents